Martha Hahn-fournier, MD | |
629 Hammond St, Ph#1, Chestnut Hill, MA 02467-2167 | |
(561) 573-7318 | |
Not Available |
Full Name | Martha Hahn-fournier |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Location | 629 Hammond St, Chestnut Hill, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679893317 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | ME42725 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Martha Hahn-fournier, MD 629 Hammond St, Ph#1, Chestnut Hill, MA 02467-2167 Ph: () - | Martha Hahn-fournier, MD 629 Hammond St, Ph#1, Chestnut Hill, MA 02467-2167 Ph: (561) 573-7318 |
News Archive
According to the U.S. Centers for Disease Control and Prevention, diabetes affects nearly 24 million people in the United States. In observance of National Diabetes Month, the Academy of General Dentistry (AGD) encourages those with diabetes to pay extra attention to their oral health.
Research scientist Christine Portfors will study how the brain chemical dopamine influences hearing with support from the National Institutes of Health. The work may ultimately lead to better therapies for people with hearing loss and communication problems.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity," the anxiety and distress that follow health care and medication expenses, often compounded by reduced ability to work.
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London.
› Verified 7 days ago
Cecilia Tran Hurst, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston St, Suite 303, Chestnut Hill, MA 02467 Phone: 617-383-6800 Fax: 617-383-6801 | |
Harsha Vinayak Gopal, MD, FACS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston Street, Suite 303, Chestnut Hill, MA 02467 Phone: 617-383-6800 Fax: 617-383-6801 | |
David M Vernick, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston St, #303, Chestnut Hill, MA 02467 Phone: 617-383-6800 |